Filing metadata

Accession number
0001366244-26-000005
Form type
Form 4
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
Mar 10, 2026
Reporting period
Mar 06, 2026
Description
Insider transaction

Explore SEC Filings Hub